**Question:** The drug NOT used in prostatic carcinoma:

A. Bicalutamide
B. Enzalutamide
C. Abiraterone
D. Prednisolone

**Core Concept:**
Prostatic carcinoma is a type of cancer that arises from the epithelial cells of the prostate gland. Treatment options for prostatic carcinoma primarily focus on hormone therapy, chemotherapy, and targeted therapy.

**Why the Correct Answer is Right:**
Drugs like Bicalutamide, Enzalutamide, and Abiraterone are examples of targeted therapy drugs used in the treatment of prostatic carcinoma. These drugs inhibit the androgen receptor pathway, which plays a crucial role in the growth of prostate cancer cells.

**Why Each Wrong Option is Incorrect:**
Prednisolone is a corticosteroid used for its anti-inflammatory and immunosuppressive properties. It is not a targeted therapy drug but rather a immunosuppressive agent, making it unsuitable for treating prostatic carcinoma.

**Core Concept:**
Prednisolone belongs to the class of drugs known as corticosteroids, which are synthesized from cortisol. Corticosteroids are used for their anti-inflammatory and immunosuppressive effects, rather than targeting prostatic carcinoma cells directly.

**Clinical Pearl:**
In prostatic carcinoma treatment, the choice of therapy depends on factors such as the stage of cancer, patient factors (e.g., age, comorbidities), and the response to treatment. It is essential for medical students and practicing physicians to understand the appropriate drug classes (hormone therapy, chemotherapy, targeted therapy) and their mechanism of action when treating prostatic carcinoma. This knowledge is crucial for selecting the most effective therapy and avoiding the use of medications not suitable for the condition.